Ryan Halsted
Stock Analyst at RBC Capital
(n/a)
# 5,006
Out of 5,170 analysts
12
Total ratings
n/a
Success rate
-11.4%
Average return
Main Sectors:
Stocks Rated by Ryan Halsted
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOCS Doximity | Reiterates: Outperform | $44 | $24.80 | +77.42% | 1 | Mar 9, 2026 | |
| MEDP Medpace Holdings | Initiates: Outperform | $522 | $460.92 | +13.25% | 1 | Mar 3, 2026 | |
| IQV IQVIA Holdings | Initiates: Outperform | $221 | $166.47 | +32.76% | 1 | Mar 3, 2026 | |
| HCSG Healthcare Services Group | Initiates: Sector Perform | $22 | $19.16 | +14.82% | 1 | Mar 3, 2026 | |
| MDLN Medline | Maintains: Outperform | $47 → $53 | $43.59 | +21.59% | 2 | Feb 26, 2026 | |
| EVH Evolent Health | Maintains: Sector Perform | $5 → $3 | $2.74 | +9.49% | 1 | Feb 25, 2026 | |
| PRVA Privia Health Group | Reinstates: Outperform | $31 | $21.77 | +42.40% | 1 | Jan 9, 2026 | |
| TBRG TruBridge | Reinstates: Sector Perform | $23 | $15.38 | +49.54% | 1 | Jan 9, 2026 | |
| ENSG The Ensign Group | Downgrades: Underperform | n/a | $202.49 | - | 3 | Apr 28, 2017 |
Doximity
Mar 9, 2026
Reiterates: Outperform
Price Target: $44
Current: $24.80
Upside: +77.42%
Medpace Holdings
Mar 3, 2026
Initiates: Outperform
Price Target: $522
Current: $460.92
Upside: +13.25%
IQVIA Holdings
Mar 3, 2026
Initiates: Outperform
Price Target: $221
Current: $166.47
Upside: +32.76%
Healthcare Services Group
Mar 3, 2026
Initiates: Sector Perform
Price Target: $22
Current: $19.16
Upside: +14.82%
Medline
Feb 26, 2026
Maintains: Outperform
Price Target: $47 → $53
Current: $43.59
Upside: +21.59%
Evolent Health
Feb 25, 2026
Maintains: Sector Perform
Price Target: $5 → $3
Current: $2.74
Upside: +9.49%
Privia Health Group
Jan 9, 2026
Reinstates: Outperform
Price Target: $31
Current: $21.77
Upside: +42.40%
TruBridge
Jan 9, 2026
Reinstates: Sector Perform
Price Target: $23
Current: $15.38
Upside: +49.54%
The Ensign Group
Apr 28, 2017
Downgrades: Underperform
Price Target: n/a
Current: $202.49
Upside: -